Get an alert when GALPHARM INTERNATIONAL LIMITED files next

Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.

Free · confirmation link first · unsubscribe in one click

Next accounts due

2026-09-30 (in 4mo)

Last filed for 2024-12-31

Confirmation statement due

2027-04-06 (in 11mo)

Last made up 2026-03-23

Watchouts

1 item

Cash

£323K

-37.9% vs 2023

Net assets

£23K

-99.9% vs 2023

Employees

35

-58.8% vs 2023

Profit before tax

£6M

+4% vs 2023

Watchouts

Facts from the Companies House register and the latest accounts — not a rating

Name history

Renamed 1 time since incorporation

  1. GALPHARM INTERNATIONAL LIMITED 1995-12-22 → present
  2. GAL PHARM INTERNATIONAL LIMITED 1981-02-24 → 1995-12-22

Accounts

2-year trend · latest reflected 2024-12-31

Metric Trend 2023-12-312024-12-31
Turnover £123,079,000£57,374,000
Operating profit £5,756,000£4,278,000
Profit before tax £5,447,000£5,664,000
Net profit £4,152,000£4,388,000
Cash £520,000£323,000
Total assets less current liabilities £34,128,000£23,000
Net assets £34,128,000£23,000
Equity £34,128,000£23,000
Average employees 8535
Wages £3,322,000£1,506,000

Values shown as filed in the company's annual accounts. indicates the figure wasn't present under that line item in that period. About these numbers

Ratios

Computed from the line items above — sparklines read oldest → newest

Ratio Trend 2023-12-312024-12-31
Operating margin 4.7%7.5%
Net margin 3.4%7.6%
Return on capital employed 16.9%18600.0%
Current ratio 2.38x1.08x
Interest cover 6.30x12.51x

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Audit & accounting basis

Accounting basis
FRS 102
Reporting scope
Standalone (parent only)
Audit opinion
Unaudited (audit-exempt)
Going concern
Material uncertainty disclosed

“The financial statements therefore have not been prepared on a going concern basis. Instead, they have been prepared on a break-up basis reflecting the imminent liquidation and closure of the company.”

Significant events

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

People

3 active · 21 resigned

Name Role Appointed Born Nationality
LORDEN, Bradley Secretary 2025-02-21
DOHERTY, Sarah Jane Director 2025-02-03 Feb 1984 British
RUDD, Christopher Allan Director 2018-04-03 Sep 1980 British
Show 21 resigned officers
Name Role Appointed Resigned
CORCORAN, Annette Secretary 2017-05-25 2025-02-21
HEWERDINE, Mark Secretary 1998-08-01 2008-01-09
HOYLE, Melvyn Secretary 1996-03-31 1998-07-31
KAVANAGH, Niall Patrick Secretary 2014-05-27 2017-05-25
LESLIE, Craig Andrew Secretary 1995-01-11 1996-03-31
LESLIE, Graham Andrew, Dr Secretary 1995-01-11
TUCKER, Michael Andrew Secretary 2008-01-09 2014-05-27
BRASS, Andrew Ronald Director 1993-05-04
COX, Peter Noel Miller Director 1997-04-11 1999-12-31
DOSE, Sheenagh Director 2018-04-03 2018-07-11
HOLME, Richard Director 2023-01-03 2024-03-31
HOWARD, Russell Peter Director 2008-01-09 2016-02-05
LESLIE, Anne Rachel Director 1995-06-19
LESLIE, Craig Andrew Director 1992-09-01 2008-01-09
LESLIE, Graham Andrew, Dr Director 2008-01-09
LISTER, Neil Thomas Director 2016-02-05 2023-01-03
MILLS, Stuart Charles Director 2024-03-31 2025-08-31
O'SULLIVAN, Patrick Michael Director 2014-03-18 2018-04-03
RIVERS, Dominic James Director 2018-04-03 2025-02-03
THOMPSON, Philip Director 2017-09-01 2018-04-03
TUCKER, Michael Andrew Director 2008-01-09 2016-10-31

Ownership

Persons with significant control

Name Kind Nature of control Notified Status
Galpharm Healthcare Limited Corporate entity Shares 75–100% 2016-04-06 Active

Filing timeline

Last 20 of 163 total filings

Date Type Category Description
2026-04-24 CS01 confirmation-statement Confirmation statement with no updates PDF
2026-04-15 RP01AP01 officers Replacement filing of director appointment with name PDF
2026-01-22 RP01AP01 officers Replacement filing of director appointment with name PDF
2025-10-09 AA accounts Accounts with accounts type full
2025-09-02 TM01 officers Termination director company with name termination date PDF
2025-05-15 CH01 officers Change person director company with change date PDF
2025-04-03 TM01 officers Termination director company with name termination date PDF
2025-03-23 CS01 confirmation-statement Confirmation statement with no updates PDF
2025-03-07 AP03 officers Appoint person secretary company with name date PDF
2025-03-07 TM02 officers Termination secretary company with name termination date PDF
2025-02-21 AP01 officers Appoint person director company with name date PDF
2024-09-11 AA accounts Accounts with accounts type full
2024-04-15 AP01 officers Appoint person director company with name date PDF
2024-04-12 TM01 officers Termination director company with name termination date PDF
2024-03-25 CS01 confirmation-statement Confirmation statement with no updates PDF
2023-05-24 AA accounts Accounts with accounts type full
2023-03-27 CS01 confirmation-statement Confirmation statement with no updates PDF
2023-01-10 AP01 officers Appoint person director company with name date PDF
2023-01-10 TM01 officers Termination director company with name termination date PDF
2022-06-23 AA accounts Accounts with accounts type full

Public-record activity

Raw counts from Companies House — last 12–24 months

Filings
6

last 12 months

Capital events
0

last 24 months

Officers appointed
0

last 12 months

Officers resigned
1

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

Year-on-year

FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers

Official Companies House page